Favrille files $25 million debt securities, warrants shelf registration

By Devika Patel

Knoxville, Tenn., March 11 - Favrille, Inc. filed a $25 million debt securities and warrants shelf registration in an S-3 filing with the Securities and Exchange Commission.

The registration also covers 13 million common shares.

The securities may be convertible.

Proceeds will be used to fund the further development of Specifid and for other general corporate purposes, including general and administrative expenses.

Favrille is a biopharmaceutical company based in San Diego.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.